The EC pharma and patent package – what’s important to know from a patent law perspective?

    • - CEST

End of April, the European Commission presented its draft for a comprehensive reform of pharmaceutical legislation as well as draft regulations that provide for a unitary SPC, a centralised application for “classic” SPCs and an EU wide compulsory license. It is planning the biggest pharmaceutical reform in 20 years. In particular, the SPC system is to be simplified and streamlined, an EU wide compulsory licensing system shall be implemented in order to tackle future crises and emergencies and questions regarding the possibility to rely on Bolar exemptions are to be clarified.

But what can companies in the sector expect and what issues should they be aware of?

Our experts Dr. Jan Phillip Rektorschek, Verena Bertram and Julius Zacharias will explain it to you in our digital Coffee Break on May 30, 2023, starting at 10 am.

Get an overview in the morning and start the day better informed!

Register for this event

Register now: 

The European Commission's pharmaceutical reform package:

Core objectives and planned changes at a glance

Read the entire article
Read the entire article

Related events

21 June

16:00 - 19:30


How copyright works in 2023

The latest copyright developments